Introduction: Serotonergic psychedelics induce their characteristic subjective effects via activation of the serotonin 2A receptor (5-HT2AR). This structurally diverse class of drugs includes ergolines (e.g., LSD), phenethylamines (e.g., mescaline), and tryptamines (e.g., psilocin), all of which have NPS analogues that have emerged on recreational drug markets. Importantly, certain ergolines...
Introduction Psychedelic compounds such as LSD, psilocybin, mescaline, and DMT can dramatically alter visual perception. However, the extent to which visual effects of psychedelics consistently vary for different substances is an open question. The visual effects of a given psychedelic compound can range widely both across and within individuals, so datasets with large numbers of participants...
Classic psychedelics are being globally investigated for their therapeutic potential in mental disorders, however, the literature offers little information about the progress of these studies. The aim of this study is to provide perspectives and directions on the use of classic psychedelics in the treatment of mental disorders. We conducted a bibliometric analysis of publications in the Scopus...
Se analiza la cosmovisión del pueblo wixárika en el cuidado de la naturaleza, o “Madre Tierra”, en un proceso de acompañamiento en sus espacios sagrados y vida cotidiana con el objetivo de identificar las creencias, rituales y su relación con el cuidado de la naturaleza, todo ello a fin de elaborar una propuesta intercultural para limitar el cambio climático. Se aplica un diseño metodológico...
Chronic neuropathic pain is a significant public health issue affecting an estimated 1.5 billion individuals worldwide. The mechanisms underlying chronic pain are multifaceted and not fully understood. Chronic pain amplifies specific neural pathways through peripheral and central sensitization triggered by repeated exposure to noxious stimuli, ultimately resulting in physical and emotional...
Threatening events and stressful experiences can lead to maladaptive memories and related behaviors. Existing treatments often fail to address these issues linked to anxiety/stress-related disorders effectively. This review identifies dose ranges associated with specific actions across various psychedelics. We examined psilocybin/psilocin, lysergic acid diethylamide (LSD),...
Despite considerable efforts, tobacco use disorder persists as a significant public health issue. The effectiveness of current smoking cessation therapies is limited, leading to a growing interest in alternative treatment approaches such as psychedelics. The aim of this review is to evaluate the scientific evidence regarding the role of psychedelics in smoking cessation. To identify relevant...
Abstract This chapter presents findings indicating that psilocybin-induced visual distortions and impaired executive functioning originate in temporary disruptions of attentional mechanisms. It then revisits a predictive processing account of neural processing and argues that this lacks the resources to provide a unified model of the perceptual mechanisms underpinning psychedelic experiences...
This article provides an intercultural transdisciplinary perspective on the Indigenous roots of the resurging field of psychedelic science in the management of substance use disorders (SUDs). Ritual uses of entheogens (i.e., psychedelics of natural origin) are elaborate technologies for navigating, containing, and therapeutically directing non-ordinary states of consciousness induced by these...
Psychedelics have been used therapeutically for thousands of years by various cultures, and the term "novel therapeutic agent" should not describe them. The classic psychedelics are mainly tryptamines (e.g., psilocybin, DMT, LSD) and phenethylamines (e.g., MDMA, mescaline, 2C-B), with tryptamines being more studied currently. While most psychedelics are medically safe, some like ibogaine and...